Early sepsis warning: news2 versus machine learning
Part of Infections clinical trials.
This trial compares two ways to spot early signs of sepsis (a serious infection) in the hospital: a standard scoring system called NEWS2 and a machine learning tool. It looks at whether the machine learning approach can catch warnings faster or more accurately for patients admitted with a suspected infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are admitted to Kocaeli City Hospital's Anesthesiology and Reanimation Clinic
- You have a suspected infection at the time of admission
- Your vital signs are completely recorded
- You are not pregnant
- You do not have chronic kidney disease requiring dialysis
- You have not had an organ transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This trial compares different computer tools that try to predict sepsis—a serious body-wide response to infection—so doctors can spot it earlier. If you’re an adult admitted through the emergency room, your information may be used to test which tool works best.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
This study tests a home monitoring system for people who come to the ER or their doctor with a serious infection that could turn into sepsis. The goal is to see if watching you at home can help catch worsening signs early and prevent hospitalization.
This trial tests an AI-based screening tool that uses information from patients to help identify sepsis earlier. It may help doctors notice sepsis sooner and order the right tests, especially when a sepsis warning is triggered.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.